Detail Information of Post-Translational Modifications
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0173 Transporter Info | ||||
| Gene Name | SLC25A15 | ||||
| Transporter Name | Mitochondrial ornithine transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Post-Translational Modification of This DT | |||||
| Overview of SLC25A15 Modification Sites with Functional and Structural Information | |||||
| Sequence |
MKSNPAIQAA IDLTAGAAGG TACVLTGQPF DTMKVKMQTF PDLYRGLTDC CLKTYSQVGF
RGFYKGTSPA LIANIAENSV LFMCYGFCQQ VVRKVAGLDK QAKLSDLQNA AAGSFASAFA ALVLCPTELV KCRLQTMYEM ETSGKIAKSQ NTVWSVIKSI LRKDGPLGFY HGLSSTLLRE VPGYFFFFGG YELSRSFFAS GRSKDELGPV PLMLSGGVGG ICLWLAVYPV DCIKSRIQVL SMSGKQAGFI RTFINVVKNE GITALYSGLK PTMIRAFPAN GALFLAYEYS RKLMMNQLEA Y |
||||
| PTM type |
X-Malonylation
X-Oxidation
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
||||
|
Malonylation |
|||||
|---|---|---|---|---|---|
|
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon 1 |
Have the potential to influence SLC25A15 | [1] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Lysine |
Modified Location |
36 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Malonylation at SLC25A15 Lysine 36 has the potential to affect its expression or activity. | ||||
|
Oxidation |
|||||
|
Cystine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon 1 |
Have the potential to influence SLC25A15 | [2] , [3] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Cystine |
Modified Location |
23 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Oxidation at SLC25A15 Cystine 23 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon 2 |
Have the potential to influence SLC25A15 | [2] , [3] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Cystine |
Modified Location |
125 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Oxidation at SLC25A15 Cystine 125 has the potential to affect its expression or activity. | ||||
|
Phosphorylation |
|||||
|
Serine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon 1 |
Have the potential to influence SLC25A15 | [4] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
159 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A15 Serine 159 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon 2 |
Have the potential to influence SLC25A15 | [5] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
196 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A15 Serine 196 has the potential to affect its expression or activity. | ||||
|
Threonine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon 1 |
Have the potential to influence SLC25A15 | [6] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Threonine |
Modified Location |
142 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A15 Threonine 142 has the potential to affect its expression or activity. | ||||
|
Ubiquitination |
|||||
|
Lysine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon 1 |
Have the potential to influence SLC25A15 | [7] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Lysine |
Modified Location |
100 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Ubiquitination at SLC25A15 Lysine 100 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon 2 |
Have the potential to influence SLC25A15 | [8] , [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Lysine |
Modified Location |
245 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Ubiquitination at SLC25A15 Lysine 245 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.